References
- Philips BJ, Redman J, Brennan A, et al. Glucose in bronchial aspirates increases the risk of respiratory MRSA in intubated patients. Thorax. 2005;60(9):761–764.
- Baker EH, Baines DL. Airway glucose homeostasis: a new target in the prevention and treatment of pulmonary infection. Chest. 2018 Feb;153(2):507–514. PubMed PMID: 28610911; eng.
- Weinberg ED. Nutritional immunity. Host’s attempt to withold iron from microbial invaders. JAMA. 1975 Jan 6;231(1):39–41. PubMed PMID: 1243565; eng.
- Hood MI, Skaar EP. Nutritional immunity: transition metals at the pathogen–host interface [10.1038/nrmicro2836]. Nat Rev Microbiol. 2012 08//print;10(8): 525–537.
- Baker EH, Clark N, Brennan AL, et al. Hyperglycemia and cystic fibrosis alter respiratory fluid glucose concentrations estimated by breath condensate analysis. J Appl Physiol. 2007;102(5):1969–1975.
- Baker EH, Wood DM, Brennan AL, et al. Hyperglycaemia and pulmonary infection [S0029665106000309 pii]. ProcNutrSoc. 2006;65(3):227–235.
- Gill SK, Hui K, Farne H, et al. Increased airway glucose increases airway bacterial load in hyperglycaemia [Article]. Sci Rep. 2016 06/08/online;6:27636.
- Mallia P, Webber J, Gill SK, et al. Role of airway glucose in bacterial infections in chronic obstructive pulmonary disease. J Allergy Clin Immunol. Forthcoming 2017. DOI:10.1016/j.jaci.2017.10.017
- Loukides S, Polyzogopoulos D. The effect of diabetes mellitus on the outcome of patients with chronic obstructive pulmonary disease exacerbated due to respiratory infections. Respiration. 1996;63(3):170–173. PubMed PMID: 8739488; eng.
- Garnett JP, Baker EH, Naik S, et al. Metformin reduces airway glucose permeability and hyperglycaemia-induced Staphylococcus aureus load independently of effects on blood glucose. Thorax. 2013 Sep;68(9):835–845. PubMed PMID: 23709760; PubMed Central PMCID: PMC3756442.
- Pezzulo AA, Gutierrez J, Duschner KS, et al. Glucose depletion in the airway surface liquid is essential for sterility of the airways. PloS one. 2011;6(1):e16166.
- Hunt WR, Zughaier SM, Guentert DE, et al. Hyperglycemia impedes lung bacterial clearance in a murine model of cystic fibrosis-related diabetes. Am J Physiol Lung Cell Mol Physiol. 2014 Jan 1;306(1):L43–L9. PubMed PMID: 24097557; PubMed Central PMCID: PMCPmc3920212. eng.
- Garnett JP, Braun D, McCarthy AJ, et al. Fructose transport-deficient Staphylococcus aureus reveals important role of epithelial glucose transporters in limiting sugar-driven bacterial growth in airway surface liquid. Cell Mol Life Sci. 2014 Dec;71(23):4665–4673. PubMed PMID: 24810961; PubMed Central PMCID: PMCPmc4232747. eng.
- Harris JO, Swenson EW, Johnson JE. Human alveolar macrophages: comparison of phagocytic ability, glucose utilization, and ultrastructure in smokers and nonsmokers. J Clin Investig. 1970;49(11):2086–2096. PubMed PMID: PMC535784.
- Holmberg CN, Åstrand A, Wingren C, et al. Differential effect of LPS on glucose, lactate and inflammatory markers in the lungs of normal and diabetic mice. J Pulm Respir Med. 2017;2017(1):PROA–101. PubMed PMID: 29938126.
- Lee RJ, Kofonow JM, Rosen PL, et al. Bitter and sweet taste receptors regulate human upper respiratory innate immunity. J Clin Invest. 2014 Mar;124(3):1393–1405. PubMed PMID: 24531552; PubMed Central PMCID: PMCPmc3934184. eng.
- Patkee WR, Carr G, Baker EH, et al. Metformin prevents the effects of Pseudomonas aeruginosa on airway epithelial tight junctions and restricts hyperglycaemia-induced bacterial growth. J Cell Mol Med. 2016 Apr;20(4):758–764. PubMed PMID: 26837005; PubMed Central PMCID: PMCPmc4864950. eng.
- Rinne ST, Liu CF, Feemster LC, et al. Thiazolidinediones are associated with a reduced risk of COPD exacerbations. Int J Chron Obstruct Pulmon Dis. 2015;10:1591–1597. PubMed PMID: 26300638; PubMed Central PMCID: PMCPmc4536761. eng.
- Hitchings AW, Archer JR, Srivastava SA, et al. Safety of metformin in patients with chronic obstructive pulmonary disease and type 2 diabetes mellitus. Copd. 2014 Jun 10. PubMed PMID: 24915551; Eng. DOI:10.3109/15412555.2014.898052
- Investigators N-SS, Finfer S, Chittock DR, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009 Mar 26;360(13):1283–1297. PubMed PMID: 19318384.
- Astrand A, Wingren C, Benjamin A, et al. Dapagliflozin-lowered blood glucose reduces respiratory P. aeruginosa infection in diabetic mice. Br J Pharmacol. 2017 Feb 13. PubMed PMID: 28192604. DOI:10.1111/bph.13741
- Oliveira TL, Candeia-Medeiros N, Cavalcante-Araujo PM, et al. SGLT1 activity in lung alveolar cells of diabetic rats modulates airway surface liquid glucose concentration and bacterial proliferation. Sci Rep. 2016 Feb;23(6):21752. PubMed PMID: 26902517; PubMed Central PMCID: PMCPmc4763199. eng.
- Finney L, Berry M, Singanayagam A, et al. Inhaled corticosteroids and pneumonia in chronic obstructive pulmonary disease. Lancet Respir Med. 2014 Nov;2(11):919–932. PubMed PMID: 25240963.
- Farne H, Groves HT, Gill SK, et al. Comparative metabolomic sampling of upper and lower airways by four different methods to identify biochemicals that may support bacterial growth [original research]. Front Cell Infect Microbiol. 2018 Dec 18;8(432). English.
- Krismer B, Liebeke M, Janek D, et al. Nutrient limitation governs Staphylococcus aureus metabolism and niche adaptation in the human nose [10.1371/journal.ppat.1003862 doi;PPATHOGENS-D-13-02760 pii]. PLoS Pathog. 2014;10(1):e1003862.